Farringdon Capital’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
Farringdon Capital's JNJ Position: Q2 2026 in Review
Farringdon Capital reduced its Johnson & Johnson (JNJ) stake by 64% in Q2 2026, selling an estimated $435K and leaving 1,071 shares worth $272K. The position accounts for 0.13% of the portfolio, ranked #111.
Farringdon Capital first reported a position in JNJ in Q1 2025 and has held it in 4 quarters since. The position peaked at $1.2M in Q1 2025. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Farringdon Capital held 1,071 shares of Johnson & Johnson worth $272K as of Q2 2026.
- Farringdon Capital sold 1,867 Johnson & Johnson shares in Q2 2026, an estimated $435K.
- Johnson & Johnson made up 0.13% of Farringdon Capital's portfolio in Q2 2026, its #111 holding.
- Farringdon Capital first reported a position in Johnson & Johnson in Q1 2025 and has held it in 4 quarters since.
- Farringdon Capital's Johnson & Johnson position peaked at $1.2M in Q1 2025.
- 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Farringdon Capital's 13F filing for Q2 2026, filed 12 Aug 2026.